Compare Costco Wholesale Corporation (COST) vs Hims and Hers Health Inc (HIMS) Price & Performance

Costco (COST) trades at $942.25, up 0.7% on the day, showing strong operational momentum with a 28.4% ROE and 11.3% March sales growth. The stock is near its 52-week high, supported by bullish moving averages, though RSI levels indicate potential overbought conditions. Recent membership fee hikes and robust cash flow generation underscore its resilient business model.

Outlook remains positive given analyst consensus and a $1,090 price target, but elevated P/E of 45.66 poses valuation risk. Key catalysts include sustained membership growth and expansion, while risks involve competitive pressures and macroeconomic sensitivity.

Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.

The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.